Sinofn Health
New York City stands as the epicentre of the global wellness industry. From the high-velocity startup scene in Brooklyn to the established clinical nutraceutical brands on Manhattan’s 5th Avenue, the demand for precision, transparency, and innovation is unparalleled. At SINOFN, we recognize that NYC-based brands don't just need a manufacturer; they need a strategic partner who understands the rigorous regulatory landscape of the United States and the sophisticated consumer expectations of the metropolitan market.
Our OEM/ODM solutions are engineered to support the rapid scaling requirements of New York enterprises, leveraging our deep research roots with the Chinese Academy of Sciences to deliver formulations that meet and exceed global quality benchmarks.
The NYC market is characterized by a unique "Health-Optimization" culture. Consumers are no longer satisfied with generic vitamins; they demand personalized, science-backed interventions. Our data indicates a 40% year-over-year increase in demand for specialty supplements targeting metabolic health, sleep hygiene (GABA-based solutions), and high-performance cognitive support.
1. Bio-Available Delivery Systems: Moving beyond standard tableting. Our R&D team focuses on peptide powders and optimized oral liquids that ensure higher absorption rates—a critical selling point for New York’s discerning demographic.
2. Blockchain Traceability: We implement end-to-end transparency. Every batch produced for our partners can be traced back to its raw material source, ensuring the "clean label" integrity that NYC retailers and customers demand.
3. Agile Scaling: Whether it’s a direct-to-consumer (DTC) startup in Williamsburg testing the market or an established retail giant in Manhattan, our dual-track production system allows for both rapid pilot runs and high-volume industrial scaling.
Founded by Mrs. GuoHong Liu, our company is rooted in clinical compassion. Born from the need to address Phenylketonuria (PKU), our scientific methodology is built on medical necessity, not just profit margins. This "Patient-First" engineering permeates our entire product line.
Our team, led by Dr. Tan Shengjie (Peking University Medical School) and Dr. Zhang Ying (Chinese Academy of Sciences), bridges the gap between academic research and commercial application. We don't just manufacture; we innovate.
With ISO 22000, HACCP, and FSSC 22000 certifications, our facilities are audited to meet international standards. We bring this high-level assurance to every OEM contract, ensuring your brand carries the trust of a global manufacturer.